CIT (Cancer ImmunoTherapy) is an application developed by Roche. It contains update cancer immunotherapy scientific information. This platform is intended for the exclusive use by Healthcare Professionals in Taiwan. It is designed to unsolicited provide scientific updated related to cancer immunotherapy and provide clinical supporting tool related to cancer immunotherapy treatment. It features personalized and interactive design to facilitate the scientific exchange.
Developed by F. Hoffmann-La Roche.
Roche CIT is ranking in Medical & Reference
Last update was at Feb 20, 2021and the current version is 1.0.15.
To see all other keys and revenue click here 1345445370
Roche CIT have a 0a user reviews.